Intelligence · Clinical Pipeline
Vera Therapeutics Pipeline
All ClinicalTrials.gov programs at Vera Therapeutics — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
Vera Therapeutics has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Analogs, Prostaglandin E1
Vera Therapeutics
Covid19
1 trial -
Atacicept
Vera Therapeutics
IgA Nephropathy (IgAN); Berger Disease; Renal and Urinary Disorders
1 trial -
Atacicept
Vera Therapeutics
pMN
1 trial -
Atacicept
Vera Therapeutics
IgA Nephropathy (IgAN)
1 trial -
Atacicept 150 mg
Vera Therapeutics
IgA Nephropathy (IgAN)
1 trial -
Atacicept Autoinjector Combination, Atacicept
Vera Therapeutics
Treatment of IgAN
1 trial -
Atacicept Autoinjector Combination, Atacicept
Vera Therapeutics
Multiple Autoimmune Glomerular Diseases
1 trial -
Capecitabine
Vera Therapeutics
Breast Cancer
1 trial -
Genomically Directed Monotherapy
Vera Therapeutics
Malignant Neoplasm of Breast
1 trial -
Herzuma
Vera Therapeutics
HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
1 trial -
MAU868
Vera Therapeutics
BK Virus Infection
1 trial -
NestaCell®
Vera Therapeutics
COVID-19 Pneumonia
1 trial -
VS-6766, VS-6063
Vera Therapeutics
Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
1 trial
Frequently asked questions
How many pipeline programs does Vera Therapeutics have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs